2m 2m 2m 2m 2m 2m 2m
Agios Pharm (AGIO)
NASDAQ
$35.60+$0.010 (+0.03%)
Price as of Jun 23, 2026 4:10 PM EDT- $2.1BMarket Cap
- 5.28%1-Year Change
- BiotechnologyIndustry
Agios Pharm (AGIO)
$35.60+$0.010 (+0.03%)
AGIO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $35.59 | ||
Change | +$0.94 (+2.75%) | ||
Open | $34.82 | ||
High | $35.80 | ||
Low | $34.63 | ||
Previous Close | $35.10 | ||
Volume | 744,424 | ||
30-Day Average Volume | 1,118,541 | ||
1-Week Change | 10.31% | ||
1-Month Change | 24.73% | ||
1-Year Change | 5.28% | ||
3-Year Change | 30.34% | ||
5-Year Change | -38.25% | ||
Fundamentals | |||
Shares Outstanding | 59.5M | ||
Total Assets | $1.2B | ||
Market Cap | $2.1B | ||
Enterprise Value | $2.0B | ||
Period: QTR TTM FY | |||
Revenue | $20.7M | ||
Net Income | -$99.1M | ||
Free Cash Flow | -$119.7M | ||
EBIT | -$99.1M | ||
EBITDA | -$97.7M | ||
Net Working Capital | $776.0M | ||
EPS | -$1.69 | ||
Enterprise Value/EBITDA | -20 | ||
Enterprise Value/Revenue | 95 | ||
P/B | 2 | ||
P/E | -21 | ||
PEG | -2 | ||
Price/Free Cash Flow | -17 | ||
Price/Operating Cash Flow | -18 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue